Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin82.9%-2.1pp85%+0.5pp84.5%+0.5pp84%-0.3pp84.3%+1.7pp
Operating margin-17.2%-10.9pp-6.3%+1.6pp-7.9%-0.8pp-7.1%+0.9pp-8%+9.0pp
Net margin-17.6%-11.2pp-6.4%+1.7pp-8.1%-1.1pp-7%+1.0pp-8%+9.1pp
EBITDA margin-6.7%-9.8pp3%-0.2pp3.2%-0.8pp4%+0.3pp3.7%+7.7pp
Returns
Return on equity-29.4%-17.5pp-11.9%+1.2pp-13.1%-2.3pp-10.8%+0.9pp-11.7%+13.0pp
Return on assets-10.5%-6.8pp-3.7%+0.9pp-4.7%-0.7pp-4%+0.3pp-4.3%+3.9pp
Return on invested capital-42.2%-25.6pp-16.6%+6.2pp-22.8%-3.8pp-19%+0.7pp-19.7%+20.3pp
Efficiency
Asset turnover0.6×0.0×0.6×0.0×0.6×0.0×0.6×0.0×0.5×+0.1×
Inventory turnover0.7×+0.1×0.7×0.0×0.6×0.0×0.6×+0.1×0.6×0.0×
Liquidity
Current ratio-0.1×-0.2×1.2×-0.1×1.3×+0.1×1.2×+0.1×
Quick ratio0.7×-0.1×0.8×-0.1×0.9×-0.1×0.9×0.0×0.9×+0.1×
Cash ratio0.3×0.0×0.3×-0.3×0.6×0.0×0.7×+0.1×0.6×0.0×
Leverage
Debt-to-equity0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×0.2×-0.3×
Debt-to-assets0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×-0.1×
Interest coverage-17.3×-11.6×-5.6×-0.2×-5.4×-0.7×-4.7×+0.3×-5×+5.6×
Per Share
Book value per share$1.45-13.6%$1.67-4.1%$1.75-6.7%$1.87-0.4%$1.88+15.5%
Valuation
Market capitalization$97.09M+138%$59.53M+27.5%$46.68M-5.5%$49.37M-16.4%$59.09M+77.5%
Enterprise value$90.91M+207%$53.02M+45.4%$36.48M-5.0%$38.38M-21.9%$49.18M+91.3%
Price / sales2.3×+1.3×1.3×+0.2×1.1×0.0×1.2×-0.3×1.4×+0.6×
Price / book4.4×+3.0×2.4×+0.6×1.8×0.0×1.8×-0.3×2.1×+0.6×
EV / sales2.1×+1.4×1.2×+0.3×0.9×0.0×0.9×-0.3×1.2×+0.5×
Earnings yield-7.7%-0.4pp-4.8%+2.4pp-7.1%-1.2pp-5.9%-0.4pp-5.5%+13.9pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Cumberland Pharmaceuticals's profit margins?
Cumberland Pharmaceuticals (CPIX) runs a 82.9% gross margin and a -17.2% operating margin, with a -17.6% net margin.
Where do Cumberland Pharmaceuticals's ratios come from?
Every ratio is computed from Cumberland Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.